New drug combo aims to wipe out breast cancer before surgery
NCT ID NCT06604858
Summary
This study tests whether a combination of three drugs (pembrolizumab, carboplatin, and paclitaxel) given before surgery can completely eliminate cancer in patients with early-stage triple-negative breast cancer. The trial involves 30 participants who haven't had previous cancer treatments. Researchers will check if the cancer disappears from both breast tissue and lymph nodes after this pre-surgery treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Complejo Hospitalario Universitario A Coruña (CHUAC)
A Coruña, Spain
-
Complejo Hospitalario Universitario de Santiago (CHUS)
Santiago de Compostela, Spain
-
Hospital Arnau de Vilanova de Valencia
Valencia, Spain
-
Hospital Beata María Ana
Madrid, Spain
-
Hospital Cínico San Carlos
Madrid, Spain
-
Hospital Universitari Dexeus
Barcelona, Spain
-
Hospital Universitari Vall D'Hebron
Barcelona, Spain
-
Hospital Universitario Clínico San Cecilio de Granada
Granada, Spain
-
Hospital Universitario Virgen del Rocío
Seville, Spain
-
Hospital Universitario de Navarra
Pamplona, Spain
-
Institut Català d' Oncologia Girona (ICO)
Girona, Spain
Conditions
Explore the condition pages connected to this study.